← FDA DRUG APPROVALS

FDA ANDA · ANDA208818

DOXYCYCLINE HYCLATE

doxyclycline hyclate

Sponsor: LUPIN

APPLICATION
ANDA208818
TYPE
ANDA
ORIGINAL APPROVAL
2017-09-27
LATEST ACTION
2023-07-12
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

DOXYCYCLINE HYCLATEPrescription
DOXYCYCLINE HYCLATE EQ 150MG BASE · TABLET · ORAL
DOXYCYCLINE HYCLATEPrescription
DOXYCYCLINE HYCLATE EQ 75MG BASE · TABLET · ORAL

Approval history

2023-07-12Labeling · Supplement 6 · standardAP
2023-07-12Labeling · Supplement 5 · standardAP
2019-06-26Labeling · Supplement 1 · standardAP
2017-09-27UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →